GRACE KIM to Bone Neoplasms
This is a "connection" page, showing publications GRACE KIM has written about Bone Neoplasms.
Connection Strength
0.122
-
Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. Int J Cancer. 2021 04 15; 148(8):1928-1937.
Score: 0.122